| Literature DB >> 26636096 |
Abstract
The patient activation measure (PAM) is an increasingly popular instrument used as the basis for interventions to improve patient engagement and as an outcome measure to assess intervention effect. However, a PAM score may be calculated when there are missing responses, which could lead to substantial measurement error. In this paper, measurement error is systematically estimated across the full possible range of missing items (one to twelve), using simulation in which populated items were randomly replaced with missing data for each of 1,138 complete surveys obtained in a randomized controlled trial. The PAM score was then calculated, followed by comparisons of overall simulated average mean, minimum, and maximum PAM scores to the true PAM score in order to assess the absolute percentage error (APE) for each comparison. With only one missing item, the average APE was 2.5% comparing the true PAM score to the simulated minimum score and 4.3% compared to the simulated maximum score. APEs increased with additional missing items, such that surveys with 12 missing items had average APEs of 29.7% (minimum) and 44.4% (maximum). Several suggestions and alternative approaches are offered that could be pursued to improve measurement accuracy when responses are missing.Entities:
Mesh:
Year: 2015 PMID: 26636096 PMCID: PMC4655275 DOI: 10.1155/2015/270168
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Baseline characteristics of all study participants [7].
| Characteristic | Number (%) |
|---|---|
| Sample size | 512 |
| Primary condition | |
| CHF | 257 (50.2%) |
| COPD | 255 (49.8%) |
| Female | 295 (57.6%) |
| Age, mean (SD) | 66.75 (11.99) |
| Insurance | |
| Medicare | 358 (69.9%) |
| Medicaid | 52 (10.2%) |
| Commercial | 69 (13.5%) |
| None | 33 (6.4%) |
| Living conditions | |
| With spouse/caregiver | 332 (64.8%) |
| Alone | 169 (33.0%) |
| Other | 6 (1.2%) |
| Homeless | 5 (1.0%) |
| Comorbidities | |
| Cerebrovascular disease | 224 (43.8%) |
| Diabetes | 204 (39.8%) |
| Obesity | 172 (33.6%) |
| Chronic pain | 128 (25.0%) |
| Renal disease | 117 (22.9%) |
| Acute myocardial infarction | 103 (20.1%) |
| Peptic ulcer disease | 87 (17.0%) |
| Depression | 70 (13.7%) |
| Cancer | 57 (11.1%) |
| Mental disorder | 63 (12.3%) |
| Liver disease | 40 (7.8%) |
| PAM, mean (SD) | 54.03 (13.69) |
| Hospital utilization in prior 12 months | |
| Admissions (all-cause), mean (SD) | 1.78 (1.32) |
| Hospital days (all-cause), mean (SD) | 8.40 (8.65) |
| ED visits (all-cause), mean (SD) | 0.91 (1.85) |
| LOS of index admission, mean (SD) | 5.24 (4.05) |
PAM: patient activation measure; ED: emergency department; LOS: length of stay.
Unless otherwise noted.
Figure 1Mean, minimum, and maximum patient activation measure (PAM) scores derived via simulation (1,000 repetitions for each missing value level) on the entire study population. The vertical line represents the true mean of all PAM scores = 57.2.
Average absolute percent errors (APEs) between true PAM mean scores and simulated mean, minimum, and maximum scores, overall and separately by PAM levels.
| Missing | Overall | Level 1 | Level 2 | Level 3 | Level 4 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| APE (mean) | APE (min) | APE (max) | APE (mean) | APE (min) | APE (max) | APE (mean) | APE (min) | APE (max) | APE (mean) | APE (min) | APE (max) | APE (mean) | APE (min) | APE (max) | |
| 1 | 0.3% | 2.5% | 4.3% | 0.9% | 2.4% | 4.4% | 0.9% | 2.2% | 6.4% | 0.5% | 3.9% | 2.6% | 0.2% | 1.6% | 4.3% |
| 2 | 0.2% | 5.4% | 7.8% | 0.3% | 6.0% | 7.7% | 1.0% | 5.6% | 12.0% | 0.4% | 7.3% | 5.8% | 0.4% | 3.4% | 7.1% |
| 3 | 0.3% | 8.0% | 11.4% | 0.6% | 8.1% | 12.9% | 0.5% | 7.6% | 16.5% | 0.2% | 10.7% | 7.5% | 0.4% | 5.9% | 10.9% |
| 4 | 0.3% | 10.5% | 14.4% | 0.5% | 11.9% | 19.7% | 1.6% | 8.6% | 18.3% | 0.7% | 12.1% | 8.3% | 0.4% | 9.7% | 14.8% |
| 5 | 0.4% | 13.0% | 17.6% | 1.1% | 14.2% | 25.1% | 0.4% | 11.1% | 20.8% | 0.1% | 13.9% | 10.8% | 0.5% | 12.9% | 17.8% |
| 6 | 0.3% | 15.9% | 20.9% | 0.5% | 17.7% | 30.9% | 0.5% | 14.1% | 22.3% | 0.0% | 15.2% | 12.8% | 0.3% | 16.8% | 22.1% |
| 7 | 0.9% | 17.8% | 24.1% | 2.0% | 21.3% | 35.2% | 2.0% | 15.4% | 23.3% | 0.7% | 15.4% | 16.0% | 0.9% | 19.7% | 26.2% |
| 8 | 0.7% | 20.8% | 27.4% | 1.6% | 23.4% | 39.5% | 1.2% | 19.7% | 25.5% | 0.3% | 17.3% | 19.3% | 0.6% | 23.2% | 29.6% |
| 9 | 1.5% | 22.7% | 30.8% | 3.2% | 25.8% | 43.2% | 2.9% | 22.8% | 28.4% | 0.7% | 18.3% | 24.8% | 1.7% | 25.0% | 31.4% |
| 10 | 1.8% | 25.2% | 33.3% | 3.7% | 26.9% | 45.8% | 3.2% | 27.1% | 31.0% | 0.6% | 20.6% | 28.8% | 2.1% | 27.4% | 32.6% |
| 11 | 3.7% | 25.4% | 36.5% | 7.1% | 24.5% | 49.6% | 5.1% | 27.3% | 35.2% | 0.4% | 20.6% | 34.9% | 3.9% | 28.9% | 32.1% |
| 12 | 7.3% | 29.7% | 44.4% | 14.7% | 30.3% | 62.0% | 8.4% | 35.8% | 47.9% | 2.9% | 25.5% | 45.4% | 6.7% | 34.3% | 32.7% |
Figure 2Mean, minimum, and maximum patient activation measure (PAM) scores derived via simulation (1,000 repetitions at each missing value level), by PAM level. Vertical lines represent the true mean of all PAM scores per given level (40.7, 50.3, 60.3, and 75.4, for levels 1 through 4, resp.).